Identification of 4-Amino-Thieno[2,3-<italic toggle="yes">d</italic>]Pyrimidines as QcrB Inhibitors in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
ABSTRACT Antibiotic resistance is a global crisis that threatens our ability to treat bacterial infections, such as tuberculosis, caused by Mycobacterium tuberculosis. Of the 10 million cases of tuberculosis in 2017, approximately 19% of new cases and 43% of previously treated cases were caused by s...
Main Authors: | Gregory A. Harrison, Anne E. Mayer Bridwell, Megh Singh, Keshav Jayaraman, Leslie A. Weiss, Rachel L. Kinsella, Janessa S. Aneke, Kelly Flentie, Miranda E. Schene, Margaret Gaggioli, Samantha D. Solomon, Scott A. Wildman, Marvin J. Meyers, Christina L. Stallings |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-10-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mSphere.00606-19 |
Similar Items
-
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
by: Caroline S. Foo, et al.
Published: (2018-11-01) -
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions
by: Mohd. Imran, et al.
Published: (2023-06-01) -
Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of Mycobacterium tuberculosis
by: Foo, Caroline S., et al.
Published: (2019) -
The cytochrome d oxidase complex regulated by fexA is an Achilles' heel in the in vivo survival of Vibrio vulnificus
by: Wenzhi Tan, et al.
Published: (2019-01-01) -
Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans
by: Yamin Gao, et al.
Published: (2021-03-01)